SCHEMBL1695121

SCHEMBL1695121

Cc1c(C(C)C)noc1N

nearest known ligand 0.38

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
MLYCD O95822 1/20 0.38
BRD4 O60885 1/20 0.31
TDO2 P48775 1/20 0.31
MAPK14 Q16539 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11993148 0.73 MAPK14 (0.32) MAPK14
SCHEMBL22698222 0.71 MLYCD (0.32) MLYCD
SCHEMBL402583 0.69
SCHEMBL22861185 0.68 S1PR1 (0.33) MAPK14
SCHEMBL14227844 0.68 MAPK14 (0.30) MAPK14
Hydrochloric Acid SCHEMBL28751278 0.67
SCHEMBL12000463 0.67
SCHEMBL24191100 0.67 BRD4 (0.39) BRD4TDO2
SCHEMBL19102117 0.67 MLYCD (0.32) MLYCD
SCHEMBL21191286 0.66 RET (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103889978-B PROCESS FOR THE PREPARATION OF ISOXAZOLYL-METHOXY-NICOTINIC ACIDS 霍夫曼-拉罗奇有限公司 2017-02-15 CN disclosed
EP-2588467-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE AS INHIBITORS OF PI3K ACTIVITY Amgen Inc. (US) 2013-05-08 EP disclosed
WO-2012003274-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE AS INHIBITORS OF PI3K ACTIVITY AMGEN INC. (US) 2012-01-05 WO disclosed